Security Information and Event Management (SIEM) technology provides visibility across an organization's information security systems by collecting and correlating events from logs across many different sources. Security analysts use tools like a SIEM to go “threat hunting”. By correlating disparate events across systems, they can often detect Indicators of Compromise (IoC’s) that may otherwise go unnoticed on individual systems.
Ransomware. Nearly every day, we learn about another major attack on companies such as JBS, Kaseya, and Quanta, a key supplier to Apple. Along with the increase in attacks, recent reports have shown the average ransomware recovery cost skyrocketed to $1.85 million this year. And, as companies have become more willing to accept attackers’ ransom demands to restore their mission-critical operations, the average ransomware payment has jumped to more than $170,000.
The need to employ data governance over sprawling repositories is essential in any industry, but it is especially important for the life sciences. The amount and types of data produced are not easily reviewed and organized. The value and sensitivity of the data makes it a lucrative target for cyber attacks. Egnyte’s data governance features give you more control over your data integrity, data privacy, and data security policies across a multitude of public cloud repositories.
Modern drug discovery and clinical trials produce a volume of data that can quickly overwhelm local storage and bandwidth capacity. Sequencing data, scanned source files, biostatistical (SAS, R, SPSS) databases, and DICOM imaging are all hard to store and collaborate on, especially with a distributed workforce. Egnyte’s platform has been facilitating secure sharing of files for over a decade, accelerating the ability to collaborate without sacrificing security.
Organizations in the life sciences industry need to maintain regulated data in compliance with a number of global data privacy laws. Ideally, compliance is automatically ensured, and data is easily categorized. But we all know that this is not always the case in a decentralized, dynamic environment. So, how are the leading biotechs efficiently and securely managing collaboration and data?
Egnyte is excited to announce the ability for our customers to build custom apps for their domains. Now our customers can create apps with tailored actions and workflows that can help increase efficiencies and boost productivity. Create your own Application that uses Egnyte’s public API, giving you a full set of enterprise features while helping with compliance of industry standards like HIPAA and FINRA to ensure you are enterprise-ready on day one.
Life science companies must implement quality processes into procedures in order to meet regulatory requirements and endpoint validation. But the implementation of quality processes is not an easy task. Managing the process of gathering feedback and gaining approval can be slow and comlex. In today's video, we will show how to handle Standard Operating Procedures or SOPs on the Egnyte platform and how to enable Part 11-compliant workflows for the review and approval process.
For over a year the future has lacked clarity. As parts of the world start to open up and the life sciences industry ramps back up to pre-pandemic activity, the fog of uncertainty is starting to lift. We are seeing an acceleration of digital transformation across the Life Sciences industry with the adoption of decentralized trials, real world evidence, and remote monitoring.
